GovChime
Notice ID: ec367d6f1b7679c8de86318ec2c51cffCombined Synopsis/Solicitation

Forensic Toxicology Drug Testing Laboratory

Archived on November 7, 2018. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM UTC−05:00
Posted
November 24, 2017
Notice type
Combined Synopsis/Solicitation
NAICS
621511: Medical Laboratories
Agency
Department of TransportationOFFICE OF THE SECRETARY

Notice details

Office
693JK4 OST
Place of performance
1200 New Jersey Ave, WASHINGTON, 20590
PSC
Q: MEDICAL SERVICES
Last updated
Sep 25, 2026

Identifiers

Solicitation number
693JK418R500002
Notice ID
ec367d6f1b7679c8de86318ec2c51cff

Description

This solicitation is for a Full and Open Competitive procurement for a "Primary Drug Testing Lab" also known as a Forensic Toxicology Drug Testing Laboratory (FTDTL) contract which will have a Base Year and four Option Years. It is anticipated that the resulting contract will be an Indefinite Delivery/Indefinite Quantity (IDIQ) contract and the contract will specify year-by-year total Ceiling price-figures. The incumbent contractor is Alere Toxicology. The incumbent's contract number is DTOS59-13-D-00500. The incumbent contractor's address is 1111 Newton Street, Gretna, Louisiana 70053. The incumbent contractor-company is eligible to compete under this new procurement. DOT does not plan to release copies of the incumbent contract document; and, in any event, the incumbent contract document would not be of any help to offerors competing under this new procurement because DOT cannot release any of the incumbent contract document's unit-pricing-information (i.e., per-job fixed-price-figures) and structure. Under the new contract to be awarded from this solicitation, the work to be performed by the contractor will probably include (1) providing split-specimen urinalysis collection supplies; (2) preparation and shipping of collection supplies, specimens and aliquots; (3) forensic urinalysis and lab work, including comprehensive performance testing and laboratory inspections as set forth in HHS guidelines; (4) maintenance of equipment used in the project; (5) quality control; (6) maintaining chain-of-custody; (7) providing specimen validity testing; (8) providing urinalysis in accordance with initial screening protocols specified in the HHS Guidelines (9) providing urinalysis tests in accordance with confirmation protocols specified in the HHS Guidelines; (10) performing tests for other drugs listed in Schedules 1 and II of the Controlled Substances Act; (11) preparing and shipping invoices and monthly reports; (12) maintaining records; (13) providing data, reports and notifications: (14) providing management briefings; and (15) providing expert advice and testimony in connection with judicial or administrative proceedings and provide documentation pertinent to individual drug tests. The solicitation and contract's reimbursement structure consist of a series of year-by-year pricing tables, each of which list various types of drug-testing jobs, with a DOT-estimated-realistic number of each such type of job to be performed by the contractor during the project-year in question, and with a fixed unit-price for that particular project-year, each offeror will be able to compile a total proposed price for that particular type of job for that particular project-year. The resulting contract, however, will not guarantee that any such DOT-estimated-realistic number of drug-testing jobs will actually be ordered by the Government; but the resulting contract probably will guarantee a minimum level of work. IT SHALL BE THE RESPONSIBILITY OF EACH PROSPECTIVE OFFER TO CLOSELY AND FREQUENTLY MONITOR THE FEDBIZOPPS WEBSITE FOR ANY SYNOPSIS-AMENDMENTS THAT MIGHT HEREAFTER BE PUBLISHED, BECAUSE AMENDMENTS OFTEN CONTAIN CRUCIAL INFORMATION. THE DUE DATE FOR PROPOSALS IS DECEMBER 7, 2017. TELEPHONE, FAXED AND E-MAILED PROPOSALS WILL NOT BE ACCEPTED. INSTEAD, EACH OFFEROR MUST SUBMIT ITS PROPOSAL IN HARD COPY FORM.

Full description on SAM.gov

Award Overview

Mentioned in the description

From description, unverified
ear-by-year total Ceiling price-figures. The incumbent contractor is Alere Toxicology. The incumben

We searched the solicitation description for the word “incumbent” and surfaced the surrounding text. This is not a confirmed match.

Contacts

Contracting Officer

Primary Contact

James H Mowery III
Contracting Officer

Secondary Contact

Jacqueline M. Howard
Contract Specialist

Documents

No documents available.

Lifecycle

Solicitation:693JK418R500002
  1. Combined Synopsis
  1. 5×
    Combined SynopsisCurrentNov 7, 2017

    Forensic Toxicology Drug Testing Laboratory

    Notice ec367d6f1b7679c8de86318ec2c51cff on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
The Defense Prisoner of War/Missing in Action Accounting Agency (DPAA) conducts global research, investigation, recovery, and laboratory operations to identify and account for unaccounted-for Department of Defense (DoD) personnel from past conflicts. These efforts support the DoD personnel accounting mission. DPAA was established on January 30, 2015; however, its predecessor organizations have supported the personnel accounting mission for decades. DPAA operates a satellite laboratory at Offutt Air Force Base, Nebraska, which opened in June 2013. DPAA also maintains permanent detachments that support host-nation access, logistics, and in-country requirements for investigation and recovery operations. These detachments include Detachment 1 in Bangkok, Thailand; Detachment 2 in Hanoi, Vietnam; Detachment 3 in Vientiane, Laos; and Detachment Europe in Miesau, Germany. DPAA Scientific Analysis (SA), also referred to as the DPAA laboratory, is a large and diverse forensic skeletal laboratory staffed by forensic anthropologists, archaeologists, and odontologists. The laboratory performs scientific analysis to support the identification of missing personnel. In 2003, the laboratory became the second Federal laboratory to achieve accreditation under the American Society of Crime Laboratory Directors/Laboratory Accreditation Board (ASCLD/LAB) International Standards Program. Laboratory accreditation supports the DoD Defense Forensic Enterprise program and is consistent with DoD Directive 5110.10, Defense POW/MIA Accounting Agency (DPAA). DPAA regional directorates, including the Indo-Pacific (IP) Directorate and Europe-Mediterranean (EM) Directorate, conduct complex historical research and archaeological analysis in support of recovery, investigation, and disinterment missions. The regional directorates plan and execute field investigations and recovery operations worldwide. The Partnerships and Innovations Directorate supports these global field operations. This contract supports DPAA laboratory and regional-directorate requirements necessary to advance the Agency’s mission of accounting for as many missing service members as feasible each year. DPAA’s planning objective is to maintain the capacity and capability to account for 200 or more individuals annually.
-Market Research11/09/2026
This solicitation is for teleradiology services for the Immigration and Customs Enforcement (ICE) Health Service Corps (IHSC) in accordance with the terms outlined in sections A-M of this request for proposal (RFP), including all attachments (see section J). Amendment A0001 - The purpose of Amendment A0001 is to extend the proposal submission due date to 12:00 pm Central Time (CT), July 21, 2026. Amendment A0002 - The purpose of Amendment A0002 is to extend the proposal submission due date to 12:00 pm Central Time (CT), August 7, 2026. Amendment A0003 - The purpose of Amendment A0003 is to extend the proposal submission due date to 12:00 pm Central Time (CT), September 4, 2026. Amendment A0004 - The purpose of Amendment A0004 is to extend the proposal submission due date to 12:00 pm Central Time (CT), October 7, 2026. Amendment A0005 - The purpose of Amendment A0005 is to extend the proposal submission due date to 12:00 pm Central Time (CT), November 6, 2026 and attach the Standard Form 30s (SF30s) for amendments A0003 and A0004 as they were erroneously omitted. Amendment A0006 - The purpose of Amendment A0006 is to revise the RFP, PWS, and various attachments. This amendment also provides government response to timely received industry questions, re-opens the question submission period, and extends the proposal submission due date to 12:00 pm Central Time (CT), December 1, 2026. See revised documents for details.
-Solicitation12/01/2026
-AwardedOpen
Page 2 of 2 The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract (Period of Performance: Base plus four option years) to Decipher Corp. for the procurement of Decipher Genomic Prostate Cancer Testing. The testing will include: all related CPT codes, all labor, supplies, equipment, insurance, and supervision to provide the items. The off-site testing will be administered by the VA North Texas Healthcare System, Pathology & Laboratory Medicine Service, 4500 S. Lancaster Rd., Dallas, TX 75216. Item Description 0001 Provide sendout reference laboratory testing not performed in-house at VANTHCS' Pathology & Laboratory Medicine Service Lab. Test will encompass all CPT codes. Contractor will provide all labor, supplies, equipment, insurance, and supervision to provide the items. Items are to be ordered on an as needed basis exact quantities of each item cannot be determined in advance as they are based upon physician's orders. This test provides prognostic information to help guide and personalize the treatment of prostate cancer. Test predicts 5yr Metastasis and 10yr cancer-related mortality in localized prostate cancer. Total annual estimated test volume is 15. The proposed sole source procurement will be made by a pricing agreement with Decipher Corp., based upon pricing from previous contracts. The requesting activity states the off-site testing agreement is for genomic prostate cancer testing; required for the testing of post-surgery oncology patients. The sole source justification request submitted by the requesting activity stated that a sole source is required because they require genomic prostate cancer testing for patients who have previously undergone surgery to determine the likelihood of the cancer reoccurrence. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within five (5) days from the publication of this notice, a contract will be issued to Decipher Corp., without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services will Satisfy Agency Needs. All responsible sources that feel they should be considered qualified to provide the above-mentioned products may submit a response to this notice (by the response due date shown above) to Susan.Flores2@va.gov. The information provided shall include detailed (and relevant) documentation to allow the government to perform adequate market research and make a proper determination. A determination by the government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. REQUESTS FOR A SOLICITATION WILL NOT RECEIVE A RESPONSE.
-Special Notice05/11/2026
The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System , has a requirement for medical laboratory, pathology and testing analysis services. The Contractor shall be responsible for performing pre-analytic processing as defined in its laboratory manual, analysis, and reporting of analytical results and interpretation for clinical and anatomical pathology specimens as requested by participating facilities (listed below) during the contract period. The contractor shall provide Pathology and Laboratory Medicine Services, on a scheduled basis, in accordance with the specifications, terms and conditions herein. VA will be responsible for specimen collection, preparation, grossing (with the exception of, cytology specimens); global surgical pathology cases would require grossing by the contractor. The VA will accession histology and cytology cases, VistA accessioning, preservation and storage of final slides and blocks. All slides and blocks must be returned to the VA for permanent storage. NOTE: The Solicitation number in the announcement 36C26326R0063 was entered incorrectly, however, cannot be changed. The correct solicitation number is 36C26326Q0727. This number has been reconciled throughout the documents.
-Solicitation11/24/2026

Additional Details

Solicitation Number

693JK418R500002

Archive Date

Nov 7, 2018

Office Address

WASHINGTON, DC, 20590